![]() |
![]()
|
|
||||||
| Economy News English Economy News |
![]() |
|
|
LinkBack | Seçenekler | Stil |
|
|
#1 (permalink) |
|
Yeni Üye
![]() |
Reuters - ImClone Systems Inc. said on Tuesday that a late-stage trial of its cancer drug Erbitux failed to improve overall survival in patients with pancreatic cancer, sending its shares down 8 percent.
[Linkleri üyelerimiz görebilir.Üyeyseniz Mailinizi OnaylayınBurayı tıklayarak üyemiz olabilirsiniz.] |
|
|
|
![]() |
| Konuyu Toplam 1 Üye okuyor. (0 Kayıtlı üye ve 1 Misafir) | |
| Seçenekler | |
| Stil | |
|
|
Benzer Konular
|
||||
| Konu | Konuyu Başlatan | UslanmaM | Cevaplar | Son Mesaj |
| Erbitux Increases Overall Survival For Head And Neck Cancer Patients | USLANMAM | Latest Health News | 0 | 04-07-2007 07:30 PM |
| Erbitux Increases Overall Survival For Head And Neck Cancer Patients | USLANMAM | Latest Health News | 0 | 04-07-2007 07:20 PM |
| Protein Found To Shield Pancreatic Cancer Cells From Self-Destruction | USLANMAM | Latest Health News | 0 | 03-26-2007 10:10 AM |
| New Pancreatic Cancer Therapy To Be Trialed At Liverpool | USLANMAM | Latest Health News | 0 | 03-21-2007 02:30 AM |
| Link Between Smoking And Pancreatic Cancer Strengthened | USLANMAM | Latest Health News | 0 | 03-11-2007 12:50 AM |